NuView Diagnostics LLC
NuView Diagnostics provides a confirmation urine diagnostic test for prostate cancer using a novel biomarker, eliminating 1.3M prostate biopsies annually.
- Stage Product In Development
- Industry Biotechnology
- Location Park City, UT, US
- Currency USD
- Founded August 2014
- Employees 2
- Incorporation Type LLC
- Website nuviewdx.com
Company Summary
Our prostate cancer confirmation test kit, using a novel biomarker, can eliminate 1.3M prostate biopsies annually. Our simple urine test returns results in 24 hours, has 99% sensitivity and 100% specificity in the detection of prostate cancer.
The proprietary biomarker has been produced and is ready for clinical trials in the US and Europe with seven potential sites.
The test kit will be used by urologists, hospitals and labs.
Team
-
CEO -
Bob Wassman, MDAdvisor -
Chief Medical Officer -
Ed YochumChief Business Officer -
Matthew Thakur, Ph.D.Inventor
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.